Previous Article | Next Article 
Journal of Virology, December 2001, p. 11474-11482, Vol. 75, No. 23
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.23.11474-11482.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Protection against Tetanus by Needle-Free
Inoculation of Adenovirus-Vectored Nasal and Epicutaneous
Vaccines
Zhongkai
Shi,1
Mingtao
Zeng,2
Guang
Yang,1
Felix
Siegel,1
Laura J.
Cain,1
Kent R.
van
Kampen,1
Craig A.
Elmets,2 and
De-Chu C.
Tang1,2,3,*
Vaxin, Inc.,1
Department of Dermatology,2 and
Gene Therapy Center,3 University of
Alabama at Birmingham, Birmingham, Alabama
Received 30 April 2001/Accepted 30 August 2001
The effectiveness of vaccination programs would be enhanced greatly
through the availability of vaccines that can be administered simply
and, preferably, painlessly without the need for timed booster
injections. Tetanus is a prime example of a disease that is readily
preventable by vaccination but remains a major threat to public health
due to the problems associated with administration of the present
vaccine. Here we show that a protective immune response against live
Clostridium tetani infection in mice can be elicited by
an adenovirus vector encoding the tetanus toxin C fragment when
administered as a nasal or epicutaneous vaccine. The results suggest
that these vaccination modalities would be effective needle-free
alternatives. This is the first demonstration that absorption of a
small number of vectored vaccines into the skin following topical
application of a patch can provide protection against live bacteria in
a disease setting.
*
Corresponding author. Mailing address: Department of
Dermatology, University of Alabama at Birmingham, VH-501, 1670 University Blvd., Birmingham, AL 35294-0019. Phone: (205) 975-5603. Fax: (205) 975-0455. E-mail:
dctang{at}uab.edu.
Journal of Virology, December 2001, p. 11474-11482, Vol. 75, No. 23
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.23.11474-11482.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Toro, H., Tang, D. C.
(2009). Protection of chickens against avian influenza with nonreplicating adenovirus-vectored vaccine. Poult. Sci.
88: 867-871
[Abstract]
[Full Text]
-
Vogt, A., Mahe, B., Costagliola, D., Bonduelle, O., Hadam, S., Schaefer, G., Schaefer, H., Katlama, C., Sterry, W., Autran, B., Blume-Peytavi, U., Combadiere, B.
(2008). Transcutaneous Anti-Influenza Vaccination Promotes Both CD4 and CD8 T Cell Immune Responses in Humans. J. Immunol.
180: 1482-1489
[Abstract]
[Full Text]
-
Armelini, M. G., Lima-Bessa, K. M., Marchetto, M. C. N., Muotri, A. R., Chigancas, V., Leite, R. A., Carvalho, H., Menck, C. F. M.
(2007). Exploring DNA damage responses in human cells with recombinant adenoviral vectors. Hum Exp Toxicol
26: 899-906
[Abstract]
-
Zhang, J., Shi, Z., Kong, F.-k., Jex, E., Huang, Z., Watt, J. M., Van Kampen, K. R., Tang, D.-c. C.
(2006). Topical Application of Escherichia coli-Vectored Vaccine as a Simple Method for Eliciting Protective Immunity.. Infect. Immun.
74: 3607-3617
[Abstract]
[Full Text]
-
DeCarlo, A.A., Whitelock, J.M.
(2006). The Role of Heparan Sulfate and Perlecan in Bone-regenerative Procedures. JDR
85: 122-132
[Abstract]
[Full Text]
-
Marchetto, M. C. N., Muotri, A. R., Burns, D. K., Friedberg, E. C., Menck, C. F. M.
(2004). Gene transduction in skin cells: Preventing cancer in xeroderma pigmentosum mice. Proc. Natl. Acad. Sci. USA
101: 17759-17764
[Abstract]
[Full Text]
-
Yang, T. C., Dayball, K., Wan, Y. H., Bramson, J.
(2003). Detailed Analysis of the CD8+ T-Cell Response following Adenovirus Vaccination. J. Virol.
77: 13407-13411
[Abstract]
[Full Text]
-
Xiang, Z. Q., Gao, G. P., Reyes-Sandoval, A., Li, Y., Wilson, J. M., Ertl, H. C. J.
(2003). Oral Vaccination of Mice with Adenoviral Vectors Is Not Impaired by Preexisting Immunity to the Vaccine Carrier. J. Virol.
77: 10780-10789
[Abstract]
[Full Text]